FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379163670> ?p ?o ?g. }

• W4379163670 abstract "Tools for radiation exposure reconstruction are required to support the medical management of radiation victims in radiological or nuclear incidents. Different biological and physical dosimetry assays can be used for various exposure scenarios to estimate the dose of ionizing radiation a person has absorbed. Regular validation of the techniques through inter-laboratory comparisons (ILC) is essential to guarantee high quality results. In the current RENEB inter-laboratory comparison, the performance quality of established cytogenetic assays [dicentric chromosome assay (DCA), cytokinesis-block micronucleus assay (CBMN), stable chromosomal translocation assay (FISH) and premature chromosome condensation assay (PCC)] was tested in comparison to molecular biological assays [gamma-H2AX foci (gH2AX), gene expression (GE)] and physical dosimetry-based assays [electron paramagnetic resonance (EPR), optically or thermally stimulated luminescence (LUM)]. Three blinded coded samples (e.g., blood, enamel or mobiles) were exposed to 0, 1.2 or 3.5 Gy X-ray reference doses (240 kVp, 1 Gy/min). These doses roughly correspond to clinically relevant groups of unexposed to low exposed (0-1 Gy), moderately exposed (1-2 Gy, no severe acute health effects expected) and highly exposed individuals (>2 Gy, requiring early intensive medical care). In the frame of the current RENEB inter-laboratory comparison, samples were sent to 86 specialized teams in 46 organizations from 27 nations for dose estimation and identification of three clinically relevant groups. The time for sending early crude reports and more precise reports was documented for each laboratory and assay where possible. The quality of dose estimates was analyzed with three different levels of granularity, 1. by calculating the frequency of correctly reported clinically relevant dose categories, 2. by determining the number of dose estimates within the uncertainty intervals recommended for triage dosimetry (±0.5 Gy or ±1.0 Gy for doses <2.5 Gy or >2.5 Gy), and 3. by calculating the absolute difference (AD) of estimated doses relative to the reference doses. In total, 554 dose estimates were submitted within the 6-week period given before the exercise was closed. For samples processed with the highest priority, earliest dose estimates/categories were reported within 5-10 h of receipt for GE, gH2AX, LUM, EPR, 2-3 days for DCA, CBMN and within 6-7 days for the FISH assay. For the unirradiated control sample, the categorization in the correct clinically relevant group (0-1 Gy) as well as the allocation to the triage uncertainty interval was, with the exception of a few outliers, successfully performed for all assays. For the 3.5 Gy sample the percentage of correct classifications to the clinically relevant group (≥2 Gy) was between 89-100% for all assays, with the exception of gH2AX. For the 1.2 Gy sample, an exact allocation to the clinically relevant group was more difficult and 0-50% or 0-48% of the estimates were wrongly classified into the lowest or highest dose categories, respectively. For the irradiated samples, the correct allocation to the triage uncertainty intervals varied considerably between assays for the 1.2 Gy (29-76%) and 3.5 Gy (17-100%) samples. While a systematic shift towards higher doses was observed for the cytogenetic-based assays, extreme outliers exceeding the reference doses 2-6 fold were observed for EPR, FISH and GE assays. These outliers were related to a particular material examined (tooth enamel for EPR assay, reported as kerma in enamel, but when converted into the proper quantity, i.e. to kerma in air, expected dose estimates could be recalculated in most cases), the level of experience of the teams (FISH) and methodological uncertainties (GE). This was the first RENEB ILC where everything, from blood sampling to irradiation and shipment of the samples, was organized and realized at the same institution, for several biological and physical retrospective dosimetry assays. Almost all assays appeared comparably applicable for the identification of unexposed and highly exposed individuals and the allocation of medical relevant groups, with the latter requiring medical support for the acute radiation scenario simulated in this exercise. However, extreme outliers or a systematic shift of dose estimates have been observed for some assays. Possible reasons will be discussed in the assay specific papers of this special issue. In summary, this ILC clearly demonstrates the need to conduct regular exercises to identify research needs, but also to identify technical problems and to optimize the design of future ILCs." @default.
• W4379163670 created "2023-06-03" @default.
• W4379163670 creator A5000838527 @default.
• W4379163670 creator A5001325663 @default.
• W4379163670 creator A5002000537 @default.
• W4379163670 creator A5002766476 @default.
• W4379163670 creator A5003458572 @default.
• W4379163670 creator A5007315901 @default.
• W4379163670 creator A5008654635 @default.
• W4379163670 creator A5008919275 @default.
• W4379163670 creator A5009421160 @default.
• W4379163670 creator A5010715899 @default.
• W4379163670 creator A5011342483 @default.
• W4379163670 creator A5011581548 @default.
• W4379163670 creator A5012779941 @default.
• W4379163670 creator A5012825279 @default.
• W4379163670 creator A5014345746 @default.
• W4379163670 creator A5015211290 @default.
• W4379163670 creator A5015571650 @default.
• W4379163670 creator A5016544898 @default.
• W4379163670 creator A5016949500 @default.
• W4379163670 creator A5018177919 @default.
• W4379163670 creator A5018434502 @default.
• W4379163670 creator A5018860977 @default.
• W4379163670 creator A5021065378 @default.
• W4379163670 creator A5021856310 @default.
• W4379163670 creator A5022424817 @default.
• W4379163670 creator A5022460487 @default.
• W4379163670 creator A5022715862 @default.
• W4379163670 creator A5023242891 @default.
• W4379163670 creator A5025222343 @default.
• W4379163670 creator A5026762883 @default.
• W4379163670 creator A5027640768 @default.
• W4379163670 creator A5030834944 @default.
• W4379163670 creator A5031128196 @default.
• W4379163670 creator A5032391187 @default.
• W4379163670 creator A5032433432 @default.
• W4379163670 creator A5032994316 @default.
• W4379163670 creator A5034086106 @default.
• W4379163670 creator A5034138334 @default.
• W4379163670 creator A5034538043 @default.
• W4379163670 creator A5036129450 @default.
• W4379163670 creator A5036354373 @default.
• W4379163670 creator A5036665992 @default.
• W4379163670 creator A5038906184 @default.
• W4379163670 creator A5039752024 @default.
• W4379163670 creator A5040130470 @default.
• W4379163670 creator A5041266828 @default.
• W4379163670 creator A5042283259 @default.
• W4379163670 creator A5043801504 @default.
• W4379163670 creator A5044560724 @default.
• W4379163670 creator A5044784187 @default.
• W4379163670 creator A5046861623 @default.
• W4379163670 creator A5048447569 @default.
• W4379163670 creator A5049694370 @default.
• W4379163670 creator A5049981855 @default.
• W4379163670 creator A5050179533 @default.
• W4379163670 creator A5050275493 @default.
• W4379163670 creator A5051784102 @default.
• W4379163670 creator A5052136899 @default.
• W4379163670 creator A5052441582 @default.
• W4379163670 creator A5054899717 @default.
• W4379163670 creator A5054972542 @default.
• W4379163670 creator A5056249211 @default.
• W4379163670 creator A5058044736 @default.
• W4379163670 creator A5058958595 @default.
• W4379163670 creator A5059306730 @default.
• W4379163670 creator A5060051811 @default.
• W4379163670 creator A5060094037 @default.
• W4379163670 creator A5060385641 @default.
• W4379163670 creator A5060740936 @default.
• W4379163670 creator A5060808021 @default.
• W4379163670 creator A5061611871 @default.
• W4379163670 creator A5062180923 @default.
• W4379163670 creator A5062557342 @default.
• W4379163670 creator A5063621990 @default.
• W4379163670 creator A5063892887 @default.
• W4379163670 creator A5064642566 @default.
• W4379163670 creator A5066505045 @default.
• W4379163670 creator A5067638203 @default.
• W4379163670 creator A5068572026 @default.
• W4379163670 creator A5068767211 @default.
• W4379163670 creator A5068808260 @default.
• W4379163670 creator A5070465530 @default.
• W4379163670 creator A5071172771 @default.
• W4379163670 creator A5073875403 @default.
• W4379163670 creator A5074027917 @default.
• W4379163670 creator A5074406651 @default.
• W4379163670 creator A5074847627 @default.
• W4379163670 creator A5075776554 @default.
• W4379163670 creator A5076802927 @default.
• W4379163670 creator A5077535375 @default.
• W4379163670 creator A5078892045 @default.
• W4379163670 creator A5079974992 @default.
• W4379163670 creator A5080058199 @default.
• W4379163670 creator A5080697475 @default.
• W4379163670 creator A5081325464 @default.
• W4379163670 creator A5085171732 @default.
• W4379163670 creator A5086765866 @default.
• W4379163670 creator A5087319048 @default.

• next